News
Important Only
Baker Hughes To Provide Co₂ Compressor Technology To Saipem For Eni’S Liverpool Bay Carbon Capture And Storage Project
June 30 (Reuters) - Baker Hughes Co BKR.O:BAKER HUGHES TO PROVIDE CO₂ COMPRESSOR TECHNOLOGY TO SAIPEM FOR ENI’S LIVERPOOL BAY CARBON CAPTURE AND STORAGE PROJECTBAKER HUGHES: ORDER WAS BOOKED IN Q1 2025.Reuters
Mon, Jun 30
Plus Therapeutics Announces FDA Agreement To Initiate ReSPECT-LM Dose Optimization Trial For REYOBIQ In Leptomeningeal Metastases
June 30 (Reuters) - Plus Therapeutics Inc PSTV.O:PLUS THERAPEUTICS ANNOUNCES FDA AGREEMENT TO INITIATE RESPECT-LM DOSE OPTIMIZATION TRIAL FOR REYOBIQ™ IN LEPTOMENINGEAL METASTASESPLUS THERAPEUTICS INC - TRIAL TO EVALUATE SAFETY, PHARMACOKINETICS, AND EFFICACY ENDPOINTSPLUS THERAPEUTICS INC - TRIAL T...Reuters
Mon, Jun 30
Advent to buy majority stake in data center equipment maker LayerZero
June 30 (Reuters) - Private equity firm Advent International said on Monday it has agreed to acquire a majority stake in LayerZero Power Systems, which manufactures power infrastructure equipment for data centers.The majority stake in the Aurora, Ohio-based company is valued at about $1 billion, a s...Reuters
Mon, Jun 30
Celcuity Reports Clinical Data From Two Early Phase Studies Of Gedatolisib
June 30 (Reuters) - Celcuity Inc CELC.O:CELCUITY REPORTS CLINICAL DATA FROM TWO EARLY PHASE STUDIES OF GEDATOLISIBCELCUITY INC - PHASE 1 TRIAL SHOWS 66% SIX-MONTH RPFS RATE IN MCRPCCELCUITY INC - PHASE 2 TRIAL SHOWS 43% ORR IN HER2+ MBCReuters
Mon, Jun 30
Unicycive Therapeutics - Crl Cites Deficiencies At Third-Party Manufacturing Vendor Unrelated To Olc
June 30 (Reuters) - Unicycive Therapeutics Inc UNCY.O:UNICYCIVE THERAPEUTICS ANNOUNCES RECEIPT OF COMPLETE RESPONSE LETTER FOR OXYLANTHANUM CARBONATE FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE ON DIALYSISUNICYCIVE THERAPEUTICS INC - CRL CITES DEFICIENCIES AT THIRD...Reuters
Mon, Jun 30
King Street Closes Oversubscribed European Real Estate Special Situations Fund Ii
June 30 (Reuters) - KING STREET CLOSES OVERSUBSCRIBED EUROPEAN REAL ESTATE SPECIAL SITUATIONS FUND IIKING STREET CAPITAL MANAGEMENT, L.P - FINAL CLOSE OF FUND, HITTING ITS HARD CAP OF ABOUT $950 MILLION OF CAPITAL COMMITMENTS WITHIN 12 MONTHSFurther company coverage: [ ]Reuters
Mon, Jun 30
King Street Closes Oversubscribed European Real Estate Special Situations Fund Ii
June 30 (Reuters) - King Street Funding Trust [RIC:RIC:KSFTS.UL]:KING STREET CLOSES OVERSUBSCRIBED EUROPEAN REAL ESTATE SPECIAL SITUATIONS FUND IIKING STREET RECEIVES 950 MILLION OF CAPITAL COMMITMENTS WITHIN 12 MONTHS.Further company coverage: KSFTS.ULReuters
Mon, Jun 30
Tempus Ai Announces Proposed Convertible Senior Notes Offering
June 30 (Reuters) - Tempus AI Inc TEM.O:TEMPUS AI, INC. ANNOUNCES PROPOSED CONVERTIBLE SENIOR NOTES OFFERING TO OPTIMIZE CAPITAL STRUCTURE AND REDUCE INTEREST EXPENSETEMPUS AI INC - ANNOUNCES $400 MILLION CONVERTIBLE SENIOR NOTES OFFERINGTEMPUS AI INC - NET PROCEEDS TO REPAY $274.7 MILLION SENIOR SE...Reuters
Mon, Jun 30
Asl Strategic Value Fund Issues Open Letter To Avadel Shareholders
June 30 (Reuters) - Avadel Pharmaceuticals PLC AVDL.O:ASL STRATEGIC VALUE FUND ISSUES OPEN LETTER TO AVADEL SHAREHOLDERSASL STRATEGIC VALUE FUND: CALLS FOR ALL AVADEL SHAREHOLDERS TO VOTE AGAINST ALL DIRECTOR NOMINEES AT UPCOMING ANNUAL MEETINGReuters
Mon, Jun 30
An2 Therapeutics To Initiate Phase 2 Trial Later This Year
June 30 (Reuters) - AN2 Therapeutics Inc ANTX.O:AN2 THERAPEUTICS REPORTS KEY INSIGHTS FROM 200-PATIENT OBSERVATIONAL STUDY IN ACUTE MELIOIDOSIS, LAYING GROUNDWORK FOR PHASE 2 PROOF-OF-CONCEPT TRIAL OF EPETRABOROLEAN2 THERAPEUTICS INC - TO INITIATE PHASE 2 TRIAL LATER THIS YEARReuters
Mon, Jun 30
